Keros Therapeutics, Inc. (KROS) Earnings
|
Expand Research on KROS
| Next EPS Date | 8/12/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$1.43 | N/A | N/A | $807.14K | N/A | N/A | N/A | ||
| 5/14/26 |
Q126 | -$1.21 | -$1.03 | -$0.18 | $370K | $1.69M | N/A |  | | Details | |
| 5/7/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 5/5/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 3/4/26 | Q425 | -$0.86 | -$0.70 | -$0.16 | $385K | $2.76M | N/A | | | Details |
